In 2022, the production value of biopharmaceuticals in South Korea amounted to around 5.4 trillion South Korean won. This represents a roughly 14 percent increase compared to the previous year. The production value has increased steadily since 2012.
Value of biopharmaceuticals produced in South Korea from 2012 to 2022 (in trillion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Biopharmaceuticals export value from South Korea 2012-2022
- Premium Statistic Biopharmaceutical market size in South Korea 2012-2022
- Premium Statistic Biopharmaceutical import value in South Korea 2012-2022
- Basic Statistic Leading orphan drugs in development based on net present value 2024
- Premium Statistic Top 10 companies by global revenue from orphan drugs 2028
- Premium Statistic Herbal raw material production value in South Korea 2012-2022
- Premium Statistic Herbal raw material import value in South Korea 2012-2022
- Premium Statistic Herbal raw material market size in South Korea 2012-2022
- Premium Statistic Pharmaceutical export value from South Korea 2012-2022
- Premium Statistic Pharmaceutical import value in South Korea 2012-2022
About the region
10
- Premium Statistic Herbal raw material export value in South Korea 2012-2022
- Premium Statistic Quasi-drug import value in South Korea 2012-2022
- Premium Statistic Quasi-drug market size in South Korea 2012-2022
- Premium Statistic Medical device export value from South Korea 2012-2022
- Premium Statistic Medical device import value in South Korea 2012-2022
- Premium Statistic Medical device market size in South Korea 2012-2022
- Premium Statistic Medical device import value in South Korea 2022, by region
- Premium Statistic Successful medical device manufacturers South Korea 2022, based on production value
- Premium Statistic Number of medical device patent applications South Korea 2010-2020
- Premium Statistic Distribution of medical device patent applications South Korea 2020, by type
Selected statistics
5
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
- Basic Statistic AstraZeneca's revenue from top product Pulmicort 2006-2023
Other regions
10
- Premium Statistic Number of orphan designations accepted in the U.S. 2003-2023
- Premium Statistic Leading orphan designations in the EU by indication 2015
- Basic Statistic Orphan drugs sales share among top pharma companies 2028 forecast
- Basic Statistic Medical cannabis prescriptions in Germany in 2019, by condition
- Premium Statistic Colorado's medical cannabis spending 2018-2024
- Basic Statistic Alaska's medical cannabis spending 2018-2024
- Basic Statistic Illinois' medical cannabis sales value U.S. 2018-2024
- Basic Statistic Vermont's medical cannabis sales value U.S. 2018-2024
- Basic Statistic Oregon's medical cannabis sales value U.S. 2018-2024
- Basic Statistic Medical cannabis prescribed in Czechia 2015-2020
Related statistics
10
- Premium Statistic Medical device export value South Korea 2022, by destination
- Premium Statistic Medical device import value South Korea 2022, by country
- Premium Statistic Medical devices export value South Korea 2022, by product
- Premium Statistic Medical devices import value South Korea 2022, by product
- Premium Statistic Sales revenue of JW Pharmaceutical 2014-2022
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic Sales revenue distribution of JW Pharmaceutical South Korea 2022, by channel
- Premium Statistic Sales revenue of GC Pharma 2015-2023
Further related statistics
9
- Global pharmaceutical pipeline by therapy area 2013-2017
- Merck & Co total assets 2009-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Walgreens operating income in the U.S. 2005-2023
- Leading European medtech countries based on market capitalization 2014
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
Further Content: You might find this interesting as well
Statistics
- Global pharmaceutical pipeline by therapy area 2013-2017
- Merck & Co total assets 2009-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Walgreens operating income in the U.S. 2005-2023
- Leading European medtech countries based on market capitalization 2014
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
MFDS (South Korea). (December 28, 2023). Value of biopharmaceuticals produced in South Korea from 2012 to 2022 (in trillion South Korean won) [Graph]. In Statista. Retrieved May 15, 2024, from https://www.statista.com/statistics/780885/south-korea-biopharmaceutical-production-value/
MFDS (South Korea). "Value of biopharmaceuticals produced in South Korea from 2012 to 2022 (in trillion South Korean won)." Chart. December 28, 2023. Statista. Accessed May 15, 2024. https://www.statista.com/statistics/780885/south-korea-biopharmaceutical-production-value/
MFDS (South Korea). (2023). Value of biopharmaceuticals produced in South Korea from 2012 to 2022 (in trillion South Korean won). Statista. Statista Inc.. Accessed: May 15, 2024. https://www.statista.com/statistics/780885/south-korea-biopharmaceutical-production-value/
MFDS (South Korea). "Value of Biopharmaceuticals Produced in South Korea from 2012 to 2022 (in Trillion South Korean Won)." Statista, Statista Inc., 28 Dec 2023, https://www.statista.com/statistics/780885/south-korea-biopharmaceutical-production-value/
MFDS (South Korea), Value of biopharmaceuticals produced in South Korea from 2012 to 2022 (in trillion South Korean won) Statista, https://www.statista.com/statistics/780885/south-korea-biopharmaceutical-production-value/ (last visited May 15, 2024)
Value of biopharmaceuticals produced in South Korea from 2012 to 2022 (in trillion South Korean won) [Graph], MFDS (South Korea), December 28, 2023. [Online]. Available: https://www.statista.com/statistics/780885/south-korea-biopharmaceutical-production-value/